HMR's Arava May Be Ripe For Review By Cigna Soon After 6-Month Delay
Executive Summary
Hoechst Marion Roussel's arthritis immunotherapy Arava is likely to be considered for coverage by the large Cigna Healthcare prescription plan, which represents about 1% of total U.S annual drug purchases.
You may also be interested in...
Avandia 90% Formulary Acceptance Achieved At One Month Post-Launch - SB
SmithKline Beecham/Bristol-Myers Squibb's Avandia has been "very quickly embraced" by managed care and is reimbursed by 90% of plans, SmithKline Beecham Chief Operating Officer Jean-Pierre Garnier, PhD, reported Sept. 16 at the Bear Stearns health care conference in New York City.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011